Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis

Clinical trial NCT00757042 · COMPLETED

Trial details

NCT number: NCT00757042
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Atopic Dermatitis Healthy Volunteers

Start date: 2008-09-18
Primary completion: 2011-01-05
Enrollment: 78

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.